Skip to main content

Newsroom

Please see below links to the most recent news and events for IDEAYA.

 

Media Contacts News Alerts LinkedIn

 
Latest Press
Dec 5, 2023

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor...

Dec 4, 2023

Entered into Clinical Study Collaboration and Supply Agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with sacituzumab-govitecan-hziy ("Trodelvy") Gilead's Trop-2...

Dec 3, 2023

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced agenda topics for its Investor R&D...

All News

Featured Stories
Stay up-to-date with us
GET EMAIL ALERTS
* Required Fields
Close Menu